Search Results

Impact of OATP transporters on pharmacokinetics

Authors: Kalliokoski, A; Niemi, M

Source: British Journal of Pharmacology, Volume 158, Number 3, October 2009 , pp. 693-705(13)

Publisher: Blackwell Publishing

Repaglinide: Hypoglycaemia treated with octreotide in an elderly patient: case report

Source: Reactions, Volume 1, Number 1268, 2009-09-05 , pp. 26-26(1)

Publisher: Adis International

Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control

Authors: Raskin; Lewin; Reinhardt; Lyness

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 10, October 2009 , pp. 947-952(6)

Publisher: Blackwell Publishing

Oral Antidiabetic Agents: Anti-Atherosclerotic Properties Beyond Glucose Lowering?

Authors: Papanas, N.; Maltezos, E.

Source: Current Pharmaceutical Design, Volume 15, Number 27, September 2009 , pp. 3179-3192(14)

Publisher: Bentham Science Publishers

Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet

Authors: Raskin, P.; Lewin, A.; Reinhardt, R.; Lyness, W.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 9, September 2009 , pp. 865-873(9)

Publisher: Blackwell Publishing

MODULATION OF NITROSATIVE/OXIDATIVE STRESS IN THE LUNG OF HYPERGLYCEMIC RABBITS BY TWO ANTIDIABETICS, PIOGLITAZONE AND REPAGLINIDE

Authors: Gumieniczek, Anna; Krzywdzinska, Marta; Nowak, Magdalena

Source: Experimental Lung Research, Volume 35, Number 5, June 2009 , pp. 371-379(9)

Publisher: Informa Healthcare

Co-solvent solubilization of some poorly-soluble antidiabetic drugs

Authors: Seedher, Neelam; Kanojia, Mamta

Source: Pharmaceutical Development and Technology, Volume 14, Number 2, April 2009 , pp. 185-192(8)

Publisher: Informa Healthcare

Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial

Authors: Derosa, Giuseppe; Salvadeo, Sibilla A. T.; D'Angelo, Angela; Ferrari, Ilaria; Mereu, Roberto; Palumbo, Ilaria; Maffioli, Pamela; Randazzo, Sabrina; Cicero, Arrigo F. G.

Source: Current Medical Research and Opinion, Volume 25, Number 3, March 2009 , pp. 607-615(9)

Publisher: Informa Healthcare

Hypoglycaemia with Oral Antidiabetic Drugs: Results from Prescription-Event Monitoring Cohorts of Rosiglitazone, Pioglitazone, Nateglinide and Repaglinide

Authors: Vlckova, Veronika; Cornelius, Victoria; Kasliwal, Rachna; Wilton, Lynda; Shakir, Saad A.W.

Source: Drug Safety, Volume 32, Number 5, 2009 , pp. 409-418(10)

Publisher: Adis International

The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose range

Authors: Kalliokoski, Annikka; Neuvonen, Mikko; Neuvonen, Pertti J.; Niemi, Mikko

Source: British Journal of Clinical Pharmacology, Volume 66, Number 6, December 2008 , pp. 818-825(8)

Publisher: Blackwell Publishing

Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes

Author: Raskin

Source: Diabetes, Obesity and Metabolism, Volume 10, Number 12, December 2008 , pp. 1167-1177(11)

Publisher: Blackwell Publishing

Reversible Binding of Antidiabetic Drugs, Repaglinide and Gliclazide, with Human Serum Albumin

Authors: Seedher, Neelam; Kanojia, Mamta

Source: Chemical Biology & Drug Design, Volume 72, Number 4, October 2008 , pp. 290-296(7)

Publisher: Blackwell Publishing

Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients

Authors: HE, Ya-yi; ZHANG, Rong; SHAO, Xin-yu; HU, Cheng; WANG, Cong-rong; LU, Jun-xi; BAO, Yu-qian; JIA, Wei-ping; XIANG, Kun-san

Source: Acta Pharmacologica Sinica, Volume 29, Number 8, August 2008 , pp. 983-989(7)

Publisher: Blackwell Publishing

Fixed-Dose Combination Tablet of Repaglinide and Metformin is Bioequivalent to Concomitantly Administered Individual Tablets of Repaglinide and Metformin: Randomized, Single-Blind, Three-Period Crossover Study in Healthy Subjects

Authors: Hoelscher, David; Chu, Pei-Ling; Lyness, William

Source: Clinical Drug Investigation, Volume 28, Number 9, 2008 , pp. 573-582(10)

Publisher: Adis International

Repaglinide/metformin approved for T2DM by US FDA.

Source: Inpharma, Volume 1, Number 1644, 2008-06-28 , pp. 18-18(1)

Publisher: Adis International

Clarithromycin/repaglinide interaction: First report of an interaction, leading to hypoglycaemia in an elderly patient: case report

Source: Reactions, Volume 1, Number 1202, 2008-05-17 , pp. 11-11(1)

Publisher: Adis International

Repaglinide PK/PD altered by SLCO1B1 polymorphism

Source: Inpharma, Volume 1, Number 1633, 2008-04-12 , pp. 19-19(1)

Publisher: Adis International

Spermicidal activity of sulfonylureas and meglitinide analogues: role of intrasperm Ca²⁺ elevation

Authors: Kumar, Naveen; Jain, Subheet; Gupta, Anshu; Tiwary, Ashok Kumar

Source: Journal of Pharmacy and Pharmacology, Volume 60, Number 3, March 2008 , pp. 323-330(8)

Publisher: Pharmaceutical Press

No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone

Authors: Kalliokoski, Annikka; Neuvonen, Mikko; Neuvonen, Pertti J.; Niemi, Mikko

Source: British Journal of Clinical Pharmacology, Volume 65, Number 1, January 2008 , pp. 78-86(9)

Publisher: Blackwell Publishing

Porous Carrier Based Floating Granular Delivery System of Repaglinide

Authors: Jain, Sunil K.; Agrawal, Govind P.; Jain, Narendra K.

Source: Drug Development and Industrial Pharmacy, Volume 33, Number 4, April 2007 , pp. 381-391(11)

Publisher: Informa Healthcare